Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

医学 肝细胞癌 阿帕蒂尼 内科学 胃肠病学 放射科 门静脉 多中心研究 血栓 肿瘤科 癌症 随机对照试验
作者
Wei-Li Xia,Xiao-Hui Zhao,Yuan Guo,Hongtao Hu,Guangshao Cao,Zhen Li,Weijun Fan,Shi‐Jun Xu,Hai-Liang Li
出处
期刊:Clinical and translational gastroenterology [Lippincott Williams & Wilkins]
卷期号:14 (5): e00581-e00581 被引量:14
标识
DOI:10.14309/ctg.0000000000000581
摘要

INTRODUCTION: The aim of this study was to compare transarterial chemoembolization (TACE) combined with apatinib and PD-1 inhibitors (TACE-AP) with TACE combined with apatinib alone (TACE-A) in the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) and to explore the prognostic factors affecting the survival of patients. METHODS: This retrospective study analyzed data of patients with HCC with PVTT who were treated with TACE-AP or TACE-A between December 2018 and June 2021. The primary end points of the study were progression-free survival (PFS) and overall survival (OS), and the secondary end points were objective response rate (ORR) and adverse events (AEs). Propensity score matching (PSM) and stabilized inverse probability weighting (sIPTW) analyses were used to reduce patient selection bias, and Cox regression analysis was used to analyze prognostic factors affecting patient survival. RESULTS: Sixty-nine and 40 patients were included in the TACE-A and TACE-AP groups, respectively. After PSM and IPTW analyses, the median PFS and median OS in the TACE-AP group were significantly higher than those in the TACE-A group (PFS: after PSM, 6.9 vs 4.0 months, P < 0.001, after IPTW, 6.5 vs 5.1 months, P < 0.001; OS: after PSM, 14.6 vs 8.5 months P < 0.001, after IPTW, 16.1 vs 10.5 months, P < 0.001). After PSM and IPTW analyses, the tumor ORR in the TACE-AP group was significantly higher than that in the TACE-A group (PSM, 53.6% vs 17.9%, P = 0.005; IPTW, 52.5% vs 28.6%, P = 0.013). All treatment-related AEs were observed to be tolerated. Multivariate Cox regression analysis showed that the main prognostic factors affecting the survival of patients were tumor number, PVTT type, alpha-fetoprotein, and treatment mode. DISCUSSION: In the treatment of patients with HCC with PVTT, TACE-AP significantly improved PFS, OS, and ORR, and the AEs were safe and controllable.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wang完成签到,获得积分10
刚刚
研友_8Yo0Xn发布了新的文献求助30
2秒前
123完成签到,获得积分10
3秒前
科研通AI6.3应助Moly采纳,获得10
3秒前
dddd发布了新的文献求助10
4秒前
4秒前
4秒前
sarah发布了新的文献求助10
4秒前
传奇3应助冷静的小之采纳,获得10
7秒前
7秒前
kiwi完成签到,获得积分20
7秒前
研友_VZG7GZ应助Zhou采纳,获得10
7秒前
Orange应助chiweiyoung采纳,获得10
7秒前
科研通AI6.2应助Zhou采纳,获得100
7秒前
7秒前
情怀应助Zhou采纳,获得10
7秒前
Ylang关注了科研通微信公众号
7秒前
8秒前
上官若男应助Zhou采纳,获得10
8秒前
科研通AI6.4应助Zhou采纳,获得10
8秒前
科研通AI6.3应助Zhou采纳,获得10
8秒前
科研通AI6.4应助duoduo采纳,获得10
8秒前
8秒前
9秒前
Xieyusen发布了新的文献求助10
9秒前
橘生饼完成签到,获得积分10
12秒前
kiwi发布了新的文献求助10
12秒前
思源应助结实吐司采纳,获得10
12秒前
zb2009gy发布了新的文献求助10
12秒前
baobaoxiong完成签到,获得积分10
13秒前
顾矜应助swordlee采纳,获得10
13秒前
lww完成签到,获得积分20
14秒前
14秒前
yiqingLin发布了新的文献求助10
14秒前
15秒前
孙星发布了新的文献求助10
15秒前
wxyalan应助紫熊采纳,获得10
15秒前
16秒前
16秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Geist der Kunst und Kultur 1000
Resistance Spot Welding Dataset for Automobile Body-in-White Quality Analysis 748
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Machine Learning for Asset Management and Pricing 600
Numerical analysis of the coupled atmosphere-ocean models (CAO II). II 600
Models for the coupled atmosphere and ocean 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7406818
求助须知:如何正确求助?哪些是违规求助? 9011312
关于积分的说明 19191493
捐赠科研通 7040011
什么是DOI,文献DOI怎么找? 3232384
关于科研通互助平台的介绍 2394473
邀请新用户注册赠送积分活动 2214572